Lymphocyte C-reactive protein ratio: A new biomarker to predict early complications after gastrointestinal oncologic surgery.

BACKGROUND Lymphocyte-to-C-reactive protein ratio (LCR) has been used as a post-surgical prognostic biomarker in patients with gastric and colorectal cancer. However, its relationship with early postoperative complications in these patients is unknown. In this study, we aimed to reveal the relationship between LCR and postoperative complications. METHODS Eighty-one patients operated for stomach and colorectal cancer between January 2020 and August 2020 were prospectively analyzed. On preoperative and postoperative days 1, 3 and 5, other inflammatory parameters, mainly LCR, neutrophil lymphocyte ratio (NLR), were recorded. The patients were divided into two groups according to Clavien-Dindo classification as stage III and higher complications major, stage I-II/non-complication minor. RESULTS Fifty seven patients were operated for colorectal cancer, 24 patients for gastric cancer. The mean age of the patients was 65.6 ± 12.6, 34.6% of them was women. Age, operation time and hospital stay were significantly different between the groups (p= 0.004, p= 0.002, p< 0.001). Major complications developed in 18 patients. On postoperative day 5, LCR found superior diagnostic accuracy in predicting major postoperative complications compared to other inflammatory markers. On the postoperative 5th day, the cut-off value of LCR was 0.0034, 88.8% (71.9-94.8) sensitivity, and 85.7% (73.6-95.4) selectivity. CONCLUSION Among different inflammatory markers, postoperative LCR is a safe and effective predictor of postoperative complications, especially after gastric and colorectal cancer surgery on day 5.

[1]  D. McMillan,et al.  Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer. , 2020, Annals of surgery.

[2]  D. Fischman,et al.  Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19 , 2020, Journal of clinical medicine research.

[3]  Jiangxia Sun,et al.  Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study. , 2020, Japanese journal of clinical oncology.

[4]  S. Lee,et al.  The neutrophil-to-lymphocyte ratio has feasible predictive value for hospital mortality in patients with small bowel obstruction in the emergency department. , 2020, The American journal of emergency medicine.

[5]  F. A. Lagunas-Rangel.  Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis , 2020, Journal of medical virology.

[6]  I. Okan,et al.  Lymphocyte–C-reactive protein ratio: a putative predictive factor for intestinal ischemia in strangulated abdominal wall hernias , 2020, Hernia.

[7]  Yihai Liu,et al.  Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis , 2019, Medicine.

[8]  D. McMillan,et al.  Lymphocyte-to-C-reactive protein ratio and score are clinically feasible biomarkers in gastric cancer patients. , 2019, Journal of Clinical Oncology.

[9]  S. Lee,et al.  Neutrophil-to-lymphocyte ratio as a feasible prognostic marker for pyogenic liver abscess in the emergency department , 2019, European Journal of Trauma and Emergency Surgery.

[10]  Masayoshi Yamamoto,et al.  The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  M. Caricato,et al.  Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma , 2016, Cancer investigation.

[12]  F. Quereshy,et al.  The neutrophil‐to‐lymphocyte ratio predicts major perioperative complications in patients undergoing colorectal surgery , 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[13]  E. Y. Kim,et al.  C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer , 2016, Surgical Endoscopy.

[14]  D. McMillan,et al.  Postoperative C-reactive protein measurement predicts the severity of complications following surgery for colorectal cancer , 2015, International Journal of Colorectal Disease.

[15]  P. Forget,et al.  Is the Neutrophil-to-Lymphocyte Ratio more correlated than C-reactive protein with postoperative complications after major abdominal surgery? , 2015, PeerJ.

[16]  P. Blanc,et al.  C-Reactive protein and procalcitonin for the early detection of postoperative complications after sleeve gastrectomy: preliminary study in 97 patients , 2015, Surgical Endoscopy.

[17]  Kazuyoshi Yamamoto,et al.  C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection , 2015, Gastric Cancer.

[18]  M. Sćepanović,et al.  C-reactive protein as an early predictor for anastomotic leakage in elective abdominal surgery , 2013, Techniques in Coloproctology.

[19]  U. Güller,et al.  Safe and Early Discharge After Colorectal Surgery Due to C-Reactive Protein: A Diagnostic Meta-Analysis of 1832 Patients , 2012, Annals of surgery.

[20]  M. Moreira,et al.  Main findings in laboratory tests diagnosis of acute appendicitis: a prospective evaluation. , 2012, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[21]  M. Büchler,et al.  C-reactive protein as early predictor for infectious postoperative complications in rectal surgery , 2007, International Journal of Colorectal Disease.

[22]  S. Walsh,et al.  Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. , 2007, International journal of surgery.

[23]  N. Ilhan,et al.  C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. , 2004, World journal of gastroenterology.